Carbylan Therapeutics
Palo Alto, US · Delaware corporation · 1 known investors
Founders & leadership
MM
MARCEE M. MARONEYExecutive
DG
DAVID GRAVETTExecutive
TM
T. MICHAEL WHITEExecutive
HL
HAYLEY LEWISExecutive
DM
DAVID M. RENZIExecutive
SB
STEVEN BASTANamed on SEC filing
TL
TIMOTHY L. TRAPPNamed on SEC filing
Board
AC
ALBERT CHABoard director
GP
DC
DAVID CLAPPERBoard director
EW
EDWARD W. UNKARTBoard director
KA
KEITH A. KATKINBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$9M disclosed across 2 rounds · 2014–2015
▶$4MraisedMar 2015 · 4 investors · Other Health CareRule 506(b)
▶$4MraisedMar 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DAVID CLAPPERDirector
- ALBERT CHADirector
- EDWARD W. UNKARTDirector
- GUY P. NOHRADirector
- MARCEE M. MARONEYExecutive Officer
- DAVID GRAVETTExecutive Officer
- KEITH A. KATKINDirector
- T. MICHAEL WHITEExecutive Officer
- REZA ZADNODirector
- HAYLEY LEWISExecutive Officer
- STEVEN L. BASTADirector
- DAVID M. RENZIExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2014 · 4 investors · Other Health CareRule 506(b)
▶$5MraisedOct 2014 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- STEVEN BASTADirector
- DAVID GRAVETTExecutive Officer
- GUY P. NOHRADirector
- HAYLEY LEWISExecutive Officer
- MARCEE M. MARONEYExecutive Officer
- ALBERT CHADirector
- DAVID M. RENZIExecutive Officer, Director
- T. MICHAEL WHITEExecutive Officer
- REZA ZADNODirector
- TIMOTHY L. TRAPPExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Carbylan Therapeutics's investors?
- Carbylan Therapeutics's investors include Alta Partners.
- How much funding has Carbylan Therapeutics raised?
- Carbylan Therapeutics has disclosed $9M raised across 2 rounds.
- Where is Carbylan Therapeutics headquartered?
- Carbylan Therapeutics is headquartered in Palo Alto, US.